Executive officer

Matthew E. Gugino

Executive Vice President-Chief Financial Officer·Danaher Corp.

About

Matthew E. Gugino will become Executive Vice President-Chief Financial Officer of Danaher effective February 28, 2026, succeeding Matthew M. McGrew.

Mr. Gugino currently serves as Danaher's Vice President-Corporate FP&A and Group CFO with responsibility for the Life Sciences Innovations businesses. Since joining Danaher in 2013, Mr. Gugino has served in a series of progressively more responsible positions in the Company's finance and investor relations organizations, including as Vice President-Investor Relations from 2014 to March 2022. He assumed the FP&A portion of his current role in July 2019 and the Group CFO portion of his current role in April 2021.

Since 2026
Age 43

Also at Danaher Corp.

RB Rainer M. Blair President & Chief Executive Officer FD Feroz Dewan Independent Director LF Linda Filler Lead Independent Director CL Charles W. Lamanna Independent Director TL Teri L. List Independent Director MR Mitchell P. Rales Director & Chairman of the Executive Committee

Roles

Organization Role Dates Details
Danaher Corp. Executive Vice President-Chief Financial Officer 2026–present Current role
Danaher Corporation Vice President-Corporate FP&A and Group CFO (Life Sciences Innovations) April 2021 – present Assumed the FP&A portion of the role in July 2019 and the Group CFO portion in April 2021.
Danaher Corporation Vice President-Investor Relations 2014 – March 2022

Related

Company Danaher Corp. Company hub Person Rainer M. Blair President & Chief Executive Officer Person Feroz Dewan Independent Director Person Linda Filler Lead Independent Director Person Charles W. Lamanna Independent Director Person Teri L. List Independent Director Person Mitchell P. Rales Director & Chairman of the Executive Committee Person Steven M. Rales Chairman of the Board Person A. Shane Sanders Independent Director Person Alan G. Spoon Independent Director Person Raymond C. Stevens, PhD Independent Director Person Elias A. Zerhouni, MD Independent Director Person Matthew R. McGrew Executive Vice President & Chief Financial Officer
Source: Danaher Corp. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo